These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22158299)

  • 1. Drugs: Lines of defence.
    Palmer R
    Nature; 2011 Dec; 480(7376):S9-10. PubMed ID: 22158299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current anti-influenza virus chemotherapy].
    Yoshioka D; Tokimatsu I; Ishii H; Kadota J
    Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influenza A, will it keep on mutating?].
    Olea-Jiménez V; Mora-Ordóñez JM; Rodríguez-Díez A; Calbo-Torrecillas F
    Med Intensiva; 2012; 36(1):64. PubMed ID: 22197172
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of H7N9 pneumonia: current perspectives.
    Cao B; Hayden FG
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1123-6. PubMed ID: 24151830
    [No Abstract]   [Full Text] [Related]  

  • 7. Swine flu outbreak. What role for antiviral drugs?
    Couzin-Frankel J
    Science; 2009 May; 324(5928):705. PubMed ID: 19423784
    [No Abstract]   [Full Text] [Related]  

  • 8. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.
    Takashita E; Ejima M; Itoh R; Miura M; Ohnishi A; Nishimura H; Odagiri T; Tashiro M
    Euro Surveill; 2014 Jan; 19(1):. PubMed ID: 24434172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters.
    Kelso A; Hurt AC
    Nat Med; 2012 Oct; 18(10):1470-1. PubMed ID: 23042350
    [No Abstract]   [Full Text] [Related]  

  • 10. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.
    Renaud C; Pergam SA; Polyak C; Jain R; Kuypers J; Englund JA; Corey L; Boeckh MJ
    Transpl Infect Dis; 2010 Dec; 12(6):513-7. PubMed ID: 21062390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza.
    Alonso M; Rodríguez-Sánchez B; Giannella M; Catalán P; Gayoso J; López Bernaldo de Quirós JC; Bouza E; García de Viedma D
    J Clin Virol; 2011 Feb; 50(2):114-8. PubMed ID: 21074490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
    Baz M; Abed Y; Boivin G
    Antiviral Res; 2007 May; 74(2):159-62. PubMed ID: 17137644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to neuraminidase inhibitors.
    Dolin R
    Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
    [No Abstract]   [Full Text] [Related]  

  • 15. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season.
    Murtaugh W; Mahaman L; Healey B; Peters H; Anderson B; Tran M; Ziese M; Carlos MP
    Public Health Rep; 2013; 128 Suppl 2(Suppl 2):75-87. PubMed ID: 23997307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S; Upshaw R; Babu YS
    Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress of neuraminidase inhibitors for anti-influenza].
    Liu AL; Wang HD; Yang F; Du GH
    Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.